CanSino Biologics Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 4/6
CanSino Biologics has a total shareholder equity of CN¥5.1B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 41.3%. Its total assets and total liabilities are CN¥8.0B and CN¥2.9B respectively.
Wichtige Informationen
41.3%
Verhältnis von Schulden zu Eigenkapital
CN¥2.09b
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | CN¥3.28b |
| Eigenkapital | CN¥5.06b |
| Gesamtverbindlichkeiten | CN¥2.93b |
| Gesamtvermögen | CN¥7.99b |
Jüngste Berichte zur Finanzlage
Is CanSino Biologics (HKG:6185) Weighed On By Its Debt Load?
Feb 06
CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?
Oct 13CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?
May 12Does CanSino Biologics (HKG:6185) Have A Healthy Balance Sheet?
Jan 09Is CanSino Biologics (HKG:6185) Using Too Much Debt?
Jul 01We Think CanSino Biologics (HKG:6185) Can Stay On Top Of Its Debt
Mar 15Recent updates
Should Shareholders Worry About CanSino Biologics Inc.'s (HKG:6185) CEO Compensation Package?
Jun 20The Consensus EPS Estimates For CanSino Biologics Inc. (HKG:6185) Just Fell Dramatically
Apr 07Is CanSino Biologics (HKG:6185) Weighed On By Its Debt Load?
Feb 06CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?
Oct 13Analysts Are More Bearish On CanSino Biologics Inc. (HKG:6185) Than They Used To Be
Sep 07CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?
May 12Does CanSino Biologics (HKG:6185) Have A Healthy Balance Sheet?
Jan 09CanSino Biologics Inc.'s (HKG:6185) Share Price Not Quite Adding Up
Sep 16Things Look Grim For CanSino Biologics Inc. (HKG:6185) After Today's Downgrade
Aug 31Should You Be Adding CanSino Biologics (HKG:6185) To Your Watchlist Today?
Aug 29Analysts Just Made A Major Revision To Their CanSino Biologics Inc. (HKG:6185) Revenue Forecasts
Jul 13Is CanSino Biologics (HKG:6185) Using Too Much Debt?
Jul 01We Think CanSino Biologics (HKG:6185) Can Stay On Top Of Its Debt
Mar 15CanSino Biologics Inc. (HKG:6185) Analysts Just Slashed Next Year's Revenue Estimates By 15%
Jan 11Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 6185's short term assets (CN¥4.4B) exceed its short term liabilities (CN¥1.8B).
Langfristige Verbindlichkeiten: 6185's short term assets (CN¥4.4B) exceed its long term liabilities (CN¥1.2B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 6185 has more cash than its total debt.
Schulden abbauen: 6185's debt to equity ratio has increased from 9.9% to 41.3% over the past 5 years.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: 6185 has sufficient cash runway for more than 3 years based on its current free cash flow.
Vorhersage Cash Runway: Insufficient data to determine if 6185 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.